Table 1 Baseline clinical characteristics of patients
Diuretic only n = 50Diuretic + Irbesartan n = 56Diuretic + Ramipril n = 45p Value
Patients’ characteristics
Mean age (SD)73 (8.4)75 (8.5)74 (6.1)NS
Female/male (%)29(58)/21(42)37(66)/19(34)27(60)/18(40)NS
Body mass index (SD) (kg/m2)26.8 (4.2)27.2 (4.1)26.8 (3.9)NS
Medical history
Hypertension (%)38 (76)40 (71)33 (73)NS
Angina/Myocardial infarction (%)9 (18)6 (11)8 (18)NS
Atrial fibrillation (%)5 (10)12 (21)7 (16)NS
Paroxysmal atrial fibrillation (%)3 (6)6 (11)4 (9)NS
Diabetes mellitus (%)10 (20)10 (18)10 (22)NS
Hyperlipidaemia (%)4 (8)7 (13)3 (7)NS
Smoker (%)5 (10)7 (13)4 (9)NS
Ex-smoker (%)19 (38)13 (23)16 (36)NS
Aetiology of heart failure
Ischaemic heart failure (%)6 (12)4 (7)7 (16)NS
Hypertension (%)40 (80)47 (84)37 (82)NS
Idiopathic4 (8)5 (9)1 (2)NS
Signs and symptoms of CHF
NYHA class
II36 (72.0)38 (67.9)30 (66.7)NS
III14 (28.0)17 (30.4)15 (33.3)NS
IV000
SBP (mean (SD))145 (23)145 (19)143 (22)NS
DBP (mean (SD))80 (14)82 (10)79 (12)NS
Pulse76 (14)77 (9)79 (13)NS
JVP ⩾6 cm (%)4 (8.0)01 (2.2)NS
Oedema (%)14 (28.0)9 (16.1)7 (15.9)NS
Third heart sound (%)3 (6.0)1 (1.8)4 (8.9)NS
Chest x ray (on admission)
Upper lobe vein prominent (%)41 (83.7)48 (88.9)38 (88.4)NS
Kerley lines (%)9 (18.4)11 (20.4)5 (11.6)NS
Interstitial oedema (%)21 (42.9)16 (29.6)12 (27.9)NS
Medical treatment
Frusemide (%)34 (68.0)45 (80.4)36 (80.0)NS
mean dosage (SD) (mg)44.0 (19)33.3 (14)33.3 (15)NS
Hydrochlorothiazide (%)3 (6.0)6 (10.7)4 (8.9)NS
mean dosage (SD) (mg)25 (0)29 (10)38 (14)NS
Indapamide (%)3 (6.0)3 (5.4)2 (4.4)NS
mean dosage (SD) (mg)1.8 (0.6)2.5 (0)2.0 (0.7)NS
Dyazide (%)6 (12.0)1 (1.8)1 (2.2)NS
α-methyldopa (%)9 (18.8)7 (13.0)10 (23.3)NS
mean dosage (SD) (mg)151 (348)93 (258)157 (327)NS
  • D, diuretic; DBP, diastolic blood pressure; NS, not significant; SD, standard deviation; SBP, systolic blood pressure.